BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8081501)

  • 1. Isolation and characterization of aclacinomycin A-non-producing Streptomyces galilaeus (ATCC 31615) mutants.
    Ylihonko K; Hakala J; Niemi J; Lundell J; Mäntsälä P
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1359-65. PubMed ID: 8081501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mutations in aclacinomycin A-non-producing Streptomyces galilaeus strains with altered glycosylation patterns.
    Räty K; Hautala A; Torkkell S; Kantola J; Mäntsälä P; Hakala J; Ylihonko K
    Microbiology (Reading); 2002 Nov; 148(Pt 11):3375-3384. PubMed ID: 12427929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin.
    Hwang CK; Kim HS; Hong YS; Kim YH; Hong SK; Kim SJ; Lee JJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1616-20. PubMed ID: 7492117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133.
    Kim HS; Hong YS; Kim YH; Yoo OJ; Lee JJ
    J Antibiot (Tokyo); 1996 Apr; 49(4):355-60. PubMed ID: 8641998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
    Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of aklavinone and aclacinomycins in vitro and in vivo by rhodomycin biosynthesis gene products.
    Wang Y; Niemi J; Mäntsälä P
    FEMS Microbiol Lett; 2002 Feb; 208(1):117-22. PubMed ID: 11934504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin.
    Räty K; Kunnari T; Hakala J; Mäntsälä P; Ylihonko K
    Mol Gen Genet; 2000 Sep; 264(1-2):164-72. PubMed ID: 11016846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides.
    Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of Streptomyces galilaeus aclacinomycins polyketide synthase (PKS) cluster.
    Räty K; Kantola J; Hautala A; Hakala J; Ylihonko K; Mäntsälä P
    Gene; 2002 Jun; 293(1-2):115-22. PubMed ID: 12137949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
    Kim HS; Kim YH; Yoo OJ; Lee JJ
    Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A.
    Hoshino T; Sekine Y; Fujiwara A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1458-62. PubMed ID: 6581152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes: clarification of actinorhodin gene functions.
    Bartel PL; Zhu CB; Lampel JS; Dosch DC; Connors NC; Strohl WR; Beale JM; Floss HG
    J Bacteriol; 1990 Sep; 172(9):4816-26. PubMed ID: 2394677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline antibiotic 2-hydroxyaclacinomycins. I. 2-Hydroxyaclacinomycin-producing recombinant obtained from aclacinomycin-blocked mutants of Streptomyces galilaeus by a technique of protoplast fusion.
    Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
    Jpn J Antibiot; 1991 Mar; 44(3):269-76. PubMed ID: 1880909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains of Streptomyces galilaeus and Streptomyces peucetius.
    Schumann G; Stengel C; Eckardt K; Ihn W
    J Basic Microbiol; 1986; 26(4):249-55. PubMed ID: 3464736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folding of the polyketide chain is not dictated by minimal polyketide synthase in the biosynthesis of mithramycin and anthracycline.
    Kantola J; Blanco G; Hautala A; Kunnari T; Hakala J; Mendez C; Ylihonko K; Mäntsälä P; Salas J
    Chem Biol; 1997 Oct; 4(10):751-5. PubMed ID: 9375253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of aklavinone biosynthesis genes from Streptomyces galilaeus.
    Tsukamoto N; Fujii I; Ebizuka Y; Sankawa U
    J Antibiot (Tokyo); 1992 Aug; 45(8):1286-94. PubMed ID: 1399850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid anthracycline antibiotics: production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus.
    Niemi J; Ylihonko K; Hakala J; Pärssinen R; Kopio A; Mäntsälä P
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1351-8. PubMed ID: 8081500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.
    Lu W; Leimkuhler C; Oberthür M; Kahne D; Walsh CT
    Biochemistry; 2004 Apr; 43(15):4548-58. PubMed ID: 15078101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.
    Johdo O; Yoshioka T; Naganawa H; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1996 Jul; 49(7):669-75. PubMed ID: 8784429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.